Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05652270 · ClinicalTrials.gov registry record · NA

Maximizing Patient Goal Attainment

A NA study of Knee Osteoarthritis and Knee Pain Chronic, sponsored by Dartmouth-Hitchcock Medical Center.

Active
Registry status
NA
Development phase
258
Enrollment target
1
Study location

NCT05652270 is a NA study of Knee Osteoarthritis and Knee Pain Chronic that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 258 participants, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05652270, a NA study of Knee Osteoarthritis and Knee Pain Chronic, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
258 participants
Enrollment target
1
Study location

Study Summary

To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.

Interventions

  • BEHAVIORAL Goal Attainment
  • BEHAVIORAL Goal Development
  • BEHAVIORAL Goal Tracking

Study Locations (1)

New Hampshire

  • Dartmouth Hitchcock Medical Center - Lebanon

Trial Details

FieldValue
Enrollment Target 258 participants
Start Date 2023-04-21
Est. Completion 2026-12-30
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT05652270

The ClinicalTrials.gov registry entry for NCT05652270 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 258 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 101 other Knee Osteoarthritis trials with a reported enrollment target (15% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Knee Osteoarthritis appearing as the primary indexed condition, and to 3 interventions - of which Goal Attainment is the first listed.

NCT05652270 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.

Frequently Asked Questions

What is clinical trial NCT05652270 about?

NCT05652270 is a clinical study titled "Maximizing Patient Goal Attainment". To evaluate the effectiveness of the goal development intervention in guiding individual patients through the identification of high quality, specific, measurable, relevant and time-bound goal for treatment.

What is the current status of trial NCT05652270?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 258 participants. The study started on 2023-04-21. Estimated completion is 2026-12-30.

What conditions does trial NCT05652270 study?

This clinical trial studies the following conditions: Knee Osteoarthritis, Knee Pain Chronic, Knee Injuries, Knee Injuries and Disorders.

What interventions are being tested in trial NCT05652270?

The interventions under investigation include: Goal Attainment (BEHAVIORAL), Goal Development (BEHAVIORAL), Goal Tracking (BEHAVIORAL).

Who is sponsoring clinical trial NCT05652270?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05652270 being conducted?

This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Knee Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.